Two Step Haplo With Radiation Conditioning
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Chronic Lymphocytic Leukemia
Related studies linked through entity extraction aliases.
COVID-19 VAX Booster Dosing in Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pirtobrutinib (LOXO-305) Versus Bendamustine Plus Rituximab (BR) in Untreated Patients With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Autologous Cells Derived Anti-CD19 CAR-Engineered T Cells With Concurrent BTK Inhibitor for B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE3
A Dose-Escalation and Expansion Study of BGB-16673 in Participants With B-Cell Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 Mutation
- Status
- UNKNOWN
- Phase
- PHASE3
A Study to Evaluate VIP152 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia or Richter Syndrome
- Status
- TERMINATED
- Phase
- PHASE1
A Trial of Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab (PVR) Versus Venetoclax and Rituximab (VR) in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study to Understand Clinical Characteristics, Treatment Pathway in Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- N/A
B-cell Chronic Lymphoid Malignancies Markers
- Status
- UNKNOWN
- Phase
- N/A
Exercise Training to Promote Resilience to Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- NA
MEOI and HRQoL in CLL Patients Treated With BTKis
- Status
- COMPLETED
- Phase
- N/A
Faecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- PHASE2
Fixed-duration Therapy With Ibrutinib and Obinutuzumab (GA-101) in Treatment-naïve Patients With CLL
- Status
- RECRUITING
- Phase
- PHASE2
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Trial of LAVA-051 in Patients with Relapsed/refractory CLL, MM, or AML
- Status
- TERMINATED
- Phase
- PHASE1
Study on the Diagnosis and Management of CLL in Italy by GIMEMA
- Status
- RECRUITING
- Phase
- N/A
Safety, Efficacy of BNT162b2 mRNA Vaccine in CLL
- Status
- UNKNOWN
- Phase
- NA
Immune Responses to COVID-19 Vaccination in Lymphoma Patients
- Status
- COMPLETED
- Phase
- N/A